IP Library Granted Patent US 10,286,164
Granted Patent B2
US 10,286,164 · App. 15/393,353 · Granted May 14, 2019

Delivery device and method

Inventor: Per Gisle Djupesland (Oslo, NO)
Assignee: OptiNose AS
A61M15/0098A61M15/009A61M15/0021A61M15/0091A61M15/08A61M16/0493A61M16/0495A61M16/0434A61M2016/0021A61M2016/0027A61M2202/064A61M2202/30A61M2210/065
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,286,164
App. No.
15/393,353
Granted
May 14, 2019
Kind
B2
Abstract

A delivery device for and method of delivering substance, in particular a vaccine, to a mucosal surface within the oral cavity of a subject, the device comprising: a mouthpiece unit to be gripped in the mouth of a subject, wherein the mouthpiece unit is configured such that, on exhalation or attempted exhalation by the subject, a pressure is developed in the oral cavity which is such as to close the oropharyngeal velum of the subject; and an oral outlet unit including at least one outlet from which substance is in use delivered to a mucosal surface within the oral cavity of the subject.

Claims (27)

1. A method of delivering a substance to an oral cavity of a subject, the method comprising:

fitting a mouthpiece unit to a mouth of the subject;

causing the subject to exhale through the mouthpiece unit, thereby causing closure of an oropharyngeal velum of the subject; and

delivering the substance from at least one substance outlet of an oral outlet unit into the oral cavity of the subject.

2. The method of claim 1 , further including causing the subject to suck a sucker element, wherein the sucker element is configured to fix the position of the at least one substance outlet relative to a hard palate of the subject.

3. The method of claim 1 , further including delivering a reflex-inducing fluid to the subject.

4. The method of claim 3 , further including delivering the substance and the reflex-inducing fluid at the same time.

5. The method of claim 3 , wherein the reflex-inducing fluid is air.

6. The method of claim 3 , wherein the reflex-inducing fluid is water.

7. The method of claim 1 , wherein the substance is a medicament.

8. The method of claim 1 , wherein the substance is a vaccine.

9. The method of claim 1 , further including delivering the substance to palatine tonsils of the subject.

10. The method of claim 1 , further including delivering the substance to a mucosal surface within the oral cavity of the subject.

11. A method of delivering a substance to an oral cavity of a subject, the method comprising:

gripping a mouthpiece unit in a mouth of the subject, wherein the mouthpiece unit includes a mouthpiece and a tongue depressor coupled to the mouthpiece;

inserting the tongue depressor to depress the tongue of the subject, the tongue depressor connected to an oral outlet unit comprising at least one substance outlet;

exhaling through the mouthpiece, the exhalation causing closure of an oropharyngeal velum of the subject; and

delivering the substance from the at least one substance outlet into the oral cavity of the subject.

12. The method of claim 11 , wherein the substance is a medicament.

13. The method of claim 11 , wherein the substance is a vaccine.

14. The method of claim 11 , wherein the tongue depressor is movable relative to the mouthpiece.

15. The method of claim 11 , wherein the oral outlet unit is positioned to deliver the substance to palatine tonsils of the subject.

16. The method of claim 11 , further including delivering a reflex-inducing fluid to the subject.

17. The method of claim 16 , further including delivering the substance and the reflex-inducing fluid at the same time.

18. The method of claim 16 , wherein the reflex-inducing fluid is air.

19. The method of claim 16 , wherein the reflex-inducing fluid is water.

20. The method of claim 11 , wherein the substance is a powder.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded May 21, 2025
From: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
To: OPTINOSE INC.
Reel/Frame 071547/0979 →
CHANGE OF ADDRESS Recorded Jan 7, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069834/0392 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2022
From: OPTINOSE AS
To: OPTINOSE INC
Reel/Frame 061546/0424 →
RELEASE OF SECURITY AGREEMENT RECORDED AT REEL 044976 FRAME 0505 Recorded Sep 13, 2019
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: OPTINOSE AS
Reel/Frame 050371/0894 →
SECURITY INTEREST Recorded Sep 13, 2019
From: OPTINOSE AS
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 050371/0913 →
SECURITY INTEREST Recorded Dec 29, 2017
From: OPTINOSE AS
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 044976/0505 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2017
From: DJUPESLAND, PER GISLE
To: OPTINOSE AS
Reel/Frame 042711/0206 →
Priority Claims (1)
GB 0311570 · May 20, 2003 · national
Continuity (4)
Continuation 14822404 · Aug 10, 2015
Continuation 13724560 · Dec 21, 2012
Continuation 10557559
Related Publication 20170333649A1 · Nov 23, 2017